tiprankstipranks
GeoVax Labs Secures Growth Funding Through Equity Sales
Company Announcements

GeoVax Labs Secures Growth Funding Through Equity Sales

Pick the best stocks and maximize your portfolio:

GeoVax Labs (GOVX) has shared an announcement.

GeoVax Labs, Inc. has successfully completed a registered direct offering, selling over 1.3 million shares and pre-funded warrants, alongside a concurrent private placement of common warrants. The offering was priced at $5 per share, with net proceeds amounting to approximately $7.85 million to be used for general corporate purposes. The company has also agreed to a 15-day lock-up period post-offering and a six-month ban on certain variable rate transactions, ensuring stability for investors. This strategic financial move aims to bolster GeoVax’s working capital and drive future growth.

For an in-depth examination of GOVX stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyGeoVax Labs receives Notice of Allowance for cancer vaccine patent
TheFlyWHO determines mpox upsurge still constitutes public health emergency
TheFlyGeoVax Labs announces interim data from Phase 2 trial of Vaccine technology
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App